Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.22−0.70 (-2.51%)
Close on Nov 17, 2026Market cap $1.57BP/E –Yield –
Enovis ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Enovis's ebitda for the twelve months ending Jul 3, 2026 was $308.80M, up 80.0% year over year. For fiscal 2025 it was $219.89M, up 44.6% from the year before. Over ten years it grew -5.9% a year on average. The highest annual figure on record is $584.28M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $219.89M | +44.6% |
| FY2024 | Dec 31, 2024 | $152.11M | +0.5% |
| FY2023 | Dec 31, 2023 | $151.40M | +14.9% |
| FY2022 | Dec 31, 2022 | $131.79M | +6.1% |
| FY2021 | Dec 31, 2021 | $124.19M | +22.1% |
| FY2020 | Dec 31, 2020 | $101.72M | -75.7% |
| FY2019 | Dec 31, 2019 | $419.22M | +80.1% |
| FY2018 | Dec 31, 2018 | $232.74M | +11.7% |
| FY2017 | Dec 31, 2017 | $208.29M | -43.0% |
| FY2016 | Dec 31, 2016 | $365.68M | -9.2% |
| FY2015 | Dec 31, 2015 | $402.66M | -31.1% |
| FY2014 | Dec 31, 2014 | $584.28M | +11.2% |
| FY2013 | Dec 31, 2013 | $525.65M | +62.5% |
| FY2012 | Dec 31, 2012 | $323.41M | +566.8% |
| FY2011 | Dec 31, 2011 | $48.50M | -5.2% |
| FY2010 | Dec 31, 2010 | $51.18M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $88.44M | +61.5% |
| Q1 FY2026 | Apr 3, 2026 | $79.89M | +223.9% |
| Q4 FY2025 | Dec 31, 2025 | $624.58M | +1085.4% |
| Q3 FY2025 | Oct 3, 2025 | -$484.11M | -1325.9% |
| Q2 FY2025 | Jul 4, 2025 | $54.76M | +154.2% |
| Q1 FY2025 | Apr 4, 2025 | $24.67M | -35.7% |
| Q4 FY2024 | Dec 31, 2024 | $52.69M | +3.6% |
| Q3 FY2024 | Sep 27, 2024 | $39.49M | +12.9% |
| Q2 FY2024 | Jun 28, 2024 | $21.54M | -74.0% |
| Q1 FY2024 | Mar 29, 2024 | $38.39M | – |
| Q4 FY2023 | Dec 31, 2023 | $50.86M | +594.2% |
| Q3 FY2023 | Sep 29, 2023 | $34.97M | +8.5% |
| Q2 FY2023 | Jun 30, 2023 | $82.93M | +45.9% |
| Q1 FY2023 | Mar 31, 2023 | -$17.36M | -149.0% |
| Q4 FY2022 | Dec 31, 2022 | $7.33M | – |
| Q3 FY2022 | Sep 30, 2022 | $32.23M | -39.0% |
| Q2 FY2022 | Jul 1, 2022 | $56.83M | +2.2% |
| Q1 FY2022 | Apr 1, 2022 | $35.40M | -71.5% |
| Q4 FY2021 | Dec 31, 2021 | -$28.86M | – |
| Q3 FY2021 | Oct 1, 2021 | $52.81M | -57.1% |
| Q2 FY2021 | Jul 2, 2021 | $55.59M | -2.1% |
| Q1 FY2021 | Apr 2, 2021 | $124.09M | +18.0% |
| Q4 FY2020 | Dec 31, 2020 | -$183.24M | -256.7% |
| Q3 FY2020 | Oct 2, 2020 | $123.01M | -10.8% |
| Q2 FY2020 | Jul 3, 2020 | $56.78M | -51.5% |
| Q1 FY2020 | Apr 3, 2020 | $105.17M | +123.0% |
| Q4 FY2019 | Dec 31, 2019 | $116.91M | – |
| Q3 FY2019 | Sep 27, 2019 | $137.97M | +87.2% |
| Q2 FY2019 | Jun 28, 2019 | $117.17M | +45.7% |
| Q1 FY2019 | Mar 29, 2019 | $47.17M | -52.4% |
| Q4 FY2018 | Dec 31, 2018 | -$2.62M | – |
| Q3 FY2018 | Sep 28, 2018 | $73.70M | -31.8% |
| Q2 FY2018 | Jun 29, 2018 | $80.40M | -24.7% |
| Q1 FY2018 | Mar 31, 2018 | $99.16M | +7.6% |
| Q4 FY2017 | Dec 31, 2017 | -$98.67M | -221.6% |
| Q3 FY2017 | Sep 29, 2017 | $108.00M | +17.6% |
| Q2 FY2017 | Jun 30, 2017 | $106.76M | – |
| Q1 FY2017 | Mar 31, 2017 | $92.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $81.15M | – |
| Q3 FY2016 | Sep 30, 2016 | $91.81M | – |
See a number that looks wrong?